Eidos Therapeutics Appoints William Lis to Board of Directors

World News: . []

SAN FRANCISCO Dec 06 2018 GLOBE NEWSWIRE -- Eidos Therapeutics Inc Eidos NasdaqEIDX a clinical stage biopharmaceutical company focused on addressing the large unmet need in transthyretin TTR amyloidosis (ATTR), today announced the appoint...

More news and information about Eidos Therapeutics, Inc.

Published By:

Globe Newswire: 21:15 GMT Thursday 6th December 2018

Published: .

Search for other references to "eidos" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us